Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/189394
Preferential Gs protein coupling of the galanin Gal1 receptor in the μ-opioid-Gal1 receptor heterotetramer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Recent studies have proposed that heteromers of μ-opioid receptors (MORs) and galanin Gal1 receptors (Gal1Rs) localized in the mesencephalon mediate the dopaminergic effects of opioids. The present study reports converging evidence, using a peptide-interfering approach combined with biophysical and biochemical techniques, including total internal reflection fluorescence microscopy, for a predominant homodimeric structure of MOR and Gal1R when expressed individually, and for their preference to form functional heterotetramers when co-expressed. Results show that a heteromerization-dependent change in the Gal1R homodimeric interface leads to a switch in G-protein coupling from inhibitory Gi to stimulatory Gs proteins. The MOR-Gal1R heterotetramer, which is thus bound to Gs via the Gal1R homodimer and Gi via the MOR homodimer, provides the framework for a canonical Gs-Gi antagonist interaction at the adenylyl cyclase level. These novel results shed light on the intense debate about the oligomeric quaternary structure of G protein-coupled receptors, their predilection for heteromer formation, and the resulting functional significance.
Matèries
Matèries (anglès)
Citació
Citació
DE OLIVEIRA, Paulo a., MORENO GUILLÉN, Estefanía, CASAJUANA-MARTIN, Nil, CASADÓ ANGUERA, Verònica, CAI, Ning-sheng, CAMACHO-HERNANDEZ, Gisela andrea, ZHU, Hu, BONIFAZI, Alessandro, HALL, Matthew d., WEINSHENKER, David, NEWMAN, Amy hauck, LOGOTHETIS, Diomedes e., CASADÓ, Vicent, PLANT, Leigh d., PARDO, Leonardo, FERRÉ, Sergi. Preferential Gs protein coupling of the galanin Gal1 receptor in the μ-opioid-Gal1 receptor heterotetramer. _Pharmacological Research_. 2022. Vol. 182, núm. 106322. [consulta: 24 de gener de 2026]. ISSN: 1043-6618. [Disponible a: https://hdl.handle.net/2445/189394]